A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

21,340

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

July 19, 2024

Study Completion Date

July 19, 2024

Conditions

Rheumatoid Arthritis

Interventions

DRUG

tofacitinib

New index treatment of tofacitinib

DRUG

tumor necrosis factor inhibitors (TNFi)

New index treatment of TNFi

DRUG

abatacept

New index treatment of abatacept

DRUG

tocilizumab or sarilumab

New index treatment of tocilizumab or sarilumab

Trial Locations (1)

Pfizer, New York